pISSN 2636-0004eISSN 2636-0012
pISSN 2636-0004Baseline Characteristics of the Patients Included in the Study
| Patient variable | Intervention group | Total | |||
|---|---|---|---|---|---|
| Group A | Group B | Group C | |||
| Mean age (yr) | 53.7 ± 16.74 | 53.38 ± 16.12 | 48.1 ± 13.6 | 51.7 ± 15.6 | 0.14 |
| Sex | |||||
| Male | 15 (31.3) | 9 (18.8) | 11 (22.9) | 35 (24.3) | 0.39 |
| Female | 33 (68.7) | 39 (81.2) | 37 (77.1) | 109 (75.7) | |
| Personal history | |||||
| Smoking | 14 (29.2) | 9 (18.8) | 11 (22.9) | 34 (23.6) | 0.51 |
| Alcohol | 2 (4.2) | 3 (6.3) | 0 (0) | 5 (3.5) | 0.37 |
| Past medical history | |||||
| Hypertension | 6 (12.5) | 7 (14.6) | 2 (4.2) | 15 (10.4) | 0.16 |
| Diabetes mellitus | 2 (4.2) | 2 (4.2) | 1 (2.1) | 5 (3.5) | 0.79 |
| Coronary artery disease | 1 (2.1) | 1 (2.1) | 0 (0) | 2 (1.4) | 0.44 |
| Laboratory investigations | |||||
| Hemoglobin (g%) | 10.979 ± 1.76 | 11.267 ± 1.49 | 11.61 ± 1.78 | 11.285 ± 1.69 | 0.18 |
| Total leucocyte count (/mm3) | 9,711.45 ± 4,929.14 | 8,971.94 ± 5,186.31 | 9,144.27 ± 5,315.51 | 9,275.89 ± 5,119.87 | 0.76 |
| Platelet (/mL) | 198,542.04 ± 118,423.17 | 196,470.83 ± 101,034.32 | 202,691.92 ± 105,587.56 | 199,234.93 ± 107,867.34 | 0.96 |
| Total bilirubin (mg/dL) | 3.21 ± 4.27 | 3.82 ± 6.65 | 2.82 ± 5.2 | 3.28 ± 5.4 | 0.66 |
| Direct bilirubin (mg/dL) | 2.36± 3.7 | 2.81 ± 5.4 | 1.79 ± 3.6 | 2.32 ± 4.3 | 0.52 |
| Indirect bilirubin (mg/dL) | 0.85 ± 0.72 | 1.22 ± 2.7 | 0.97 ± 1.7 | 1.01 ± 1.9 | 0.63 |
| SGOT (U/L) | 101.38 ± 97.2 | 107.71 ± 143.7 | 102.42 ± 112.9 | 103.83 ± 118.7 | 0.96 |
| SGPT (U/L) | 143.67 ± 155.4 | 137.54 ± 150.5 | 135.44 ± 141.5 | 138.88 ± 148.2 | 0.96 |
| Alkaline phosphatase (U/L) | 414.81 ± 351.5 | 330.48 ± 267.02 | 379.1 ± 336.3 | 374.8 ± 320.07 | 0.43 |
| Serum creatinine (mg/dL) | 0.75 ± 0.24 | 0.73 ± 0.25 | 0.75 ± 0.17 | 0.74 ± 0.22 | 0.86 |
| Urea (mg/dL) | 24.50 ± 7.7 | 26.85 ± 9.35 | 24.38 ± 7.36 | 25.24 ± 8.2 | 0.25 |
| Prothrombin time (sec) | 13.76 ± 3.59 | 14.04 ± 2.03 | 14.24 ± 3.04 | 14.01 ± 2.95 | 0.73 |
| International normalized ratio | 1.06 ± 0.21 | 1.05 ± 0.18 | 1.36 ± 2.08 | 1.16 ± 1.21 | 0.36 |
| Pancreatic enzymes | |||||
| Amylase at 2 hr (U/L) | 170.42 ± 184.76 | 367.1 ± 1,098.86 | 191.88 ± 351.37 | 243.13 ± 675.64 | 0.29 |
| Amylase at 24 hr (U/L) | 201.38 ± 211.83 | 400.48 ± 1,149.18 | 226.83 ± 370.28 | 276.23 ± 708.335 | 0.32 |
| Lipase at 2 hr (U/L) | 424.58 ± 595.609 | 988.27 ± 2,083.164 | 530.81 ± 1,359.601 | 647.89 ± 1,486.833 | 0.14 |
| Lipase at 24 hr (U/L) | 510.46 ± 711.822 | 959.69 ± 2,010.446 | 549.27 ± 1,317.85 | 673.14 ± 1,451.688 | 0.24 |